Peripheral Artery Disease in Diabetes Mellitus: Focus on Novel Treatment Options

Author(s): Andrea Demarchi, Alberto Somaschini, Stefano Cornara, Emmanuel Androulakis*

Journal Name: Current Pharmaceutical Design

Volume 26 , Issue 46 , 2020

Become EABM
Become Reviewer
Call for Editor


Diabetes mellitus (DM) and peripheral artery disease (PAD) are two clinical entities closely associated. They share many pathophysiological pathways such as inflammation, endothelial dysfunction, oxidative stress and pro-coagulative unbalance. Emerging data focusing on agents targeting these pathways may be promising. Moreover, due to the increased cardiovascular risk, there is a growing interest in cardiovascular and “pleiotropic” effects of novel glucose lowering drugs. This review summarizes the main clinical features of PAD in patients, the diagnostic process and current medical/interventional approaches, ranging from “classical treatment” to novel agents.

Keywords: Diabetes mellitus, peripheral artery disease, novel treatments, pro-coagulative unbalance, pleiotropic, endothelial dysfunction.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Published on: 30 December, 2020
Page: [5953 - 5968]
Pages: 16
DOI: 10.2174/1389201021666201126143217
Price: $65

Article Metrics

PDF: 70